Linkedin Youtube
Launch Digital Edition

Webinars and Sponsored Roundtables — Register Now

Register Now

Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience

CAP TODAY does not endorse any of the products or services named within. The roundtable is made possible by a special educational grant from Tosoh Bioscience Inc.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.

Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from OncoLens and Diaceutics.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center

CAP TODAY does not endorse any of the products or services named within. The roundtable is made possible by a special educational grant from Pillar Biosciences.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Thursday, October 1, 2026 1 PM-2 PM ET
This presentation will explore the value of in-house CGP, offer insights into the benefits and drawbacks of incorporation, and provide information about important practical factors when considering in-house implementation of CGP.

Webinar presenter Allison M. Cushman-Vokoun, MD, PhD, FCAP, Medical Director, Molecular Diagnostics and Personalized Medicine Laboratory, Director, Division of Diagnostic Molecular Pathology and Human Genetics, Henry F. Krous Professor of Pathology, University of Nebraska Medical Center

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Illumina.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.

Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Roche.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Tuesday, November 3, 2026 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.

Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Subspecialties

Interactive Product Guides

Webinars – Register Now

Automated and integrated genomic profiling of hematologic malignancies

Thursday, March 5, 2026
11:00 AM–12:00 PM ET

Learn how EuroClonality-NDC and Myeloid-NDC NGS Workflows are utilized in advancing the future of diagnostics, prognostics, and targeted therapies and how these revolutionary assays provide comprehensive genomic data that reveals mutations, structural variations, and clonal evolution patterns with remarkable resolution, enabling clinical researchers to delve deeper into the genomic landscape of hematological malignancies.

Webinar presenters David Gonzalez, PhD, FRCPath, CEO, Univ8 Genomics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY.

Register Now.

Foundation of HER2 Gastric Cancer ASCO/CAP Guidelines—Overview of the Differences Between ASCO-CAP Breast and Gastric Cancer Scoring

Wednesday, January 28, 2026
12:00 PM–1:30 PM ET

Understand the clinical relevance of HER2 as a biomarker and its importance in cancers beyond breast and gastric. Explore the nuances of HER2 IHC scoring for breast and gastric cancers. Hear expert insights on current gastric ASCO/CAP guidelines for scoring.

Webinar presenters Josef Rüschoff, MD, PhD.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY.

Register Now.

Register for our Upcoming Webinars

Wednesday, September 24, 2025 1:00 PM–2:00 PM ET

Webinar presenters Wendy Vitek, MD, Board-certified Reproductive Endocrinologist, Boston IVF’s Syracuse, NY Fertility Center, and Shirley Li, MD, PhD, Associate Professor-Clinical, Department of Pathology; Director of Clinical Pathology Services and Co-Director of the Clinical Chemistry & Toxicology Laboratory, The Ohio State University, explore Anti-Müllerian Hormone (AMH) from both analytical and clinical perspectives. Gain insights into assay performance, method comparisons, and the practical utility of AMH in reproductive health and infertility treatment.

Tuesday, October 28, 2025 12:00 PM–1:00 PM ET

Webinar presenter Sanam Loghavi, MD, Associate Professor, Dept. of Hematopathology Division of Pathology/Lab Medicine, MD Anderson Cancer Center, presents from a Pathologist’s perspective, this program will allow you to learn and understand the following:

• Prevalence and severity of the FLT3-ITD mutation in AML

• Role of pathology in FLT3 mutation detection

• Patient identification and treatment landscape

A Pathologist’s Perspective: Exploring the Expanded Clinical Utility of HER2 IHC Scoring in Metastatic Breast Cancer

Webinar presenter Pranil K. Chandra, DO, Senior Vice President, Chief Medical Officer, PathGroup, discusses the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer. You will learn about the clinical significance of identifying patients with certain low levels of HER2 in metastatic breast cancer, the evolution of the HER2 spectrum, key considerations that impact HER2 IHC scoring and interpretation, and guidance for pathologists to accurately report HER2 status.

Register for our Upcoming Webinars

Wednesday, May 21, 2025 12:00 PM–1:00 PM ET

Webinar presenter Pranil K. Chandra, DO, Senior Vice President, Chief Medical Officer, PathGroup, discusses the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer.

Tuesday, June 10, 2025 1:00 PM–2:00 PM ET

Webinar presenter Raza Hoda, MD, Staff Pathologist, Cleveland Clinic, Assistant Professor of Pathology, Cleveland Clinic Lerner College of Medicine, discusses the importance of advancements in HER2 testing, including HER2 Ultra Low.

Tuesday, June 17, 2025 1:00 PM–2:00 PM ET

Webinar presenters Emilie Lalonde, PhD, FACMG, Molecular Geneticist and Cytogeneticist, Molecular Diagnostics Division, PaLM, London Health Sciences Centre and St. Joseph’s Health Care, Assistant Professor, Pathology and Laboratory Medicine, Western University, and Cheryl A. Mather, MD Medical Director, Molecular Pathology (North Sector), Alberta Precision Laboratories, Assistant Clinical Professor, Department of Laboratory Medicine & Pathology, University of Alberta, discuss how amplicon-based NGS panels meet biomarker testing guidelines in practice including routine diagnostics, expanded workup, and copy number variation (CNV) detection.

Monday, June 23, 2025 1:00 PM–2:00 PM ET

Webinar presenters Frédérique Penault-Llorca, MD, PhD, General Director, Jean Perrin Center, Professor of Pathology, University of Clermont-Ferrand, France, and Ana Garrido-Castro, MD Breast Oncologist, Dana-Farber Cancer Institute, Assistant Professor, Harvard Medical School, Boston, Massachusetts, discuss strategies for optimizing HER2 IHC testing and reporting, as well as best-practices for overcoming challenges associated with HER2 IHC scoring, especially for lower expression of HER2.

MARKETPLACE

TRENDING